Biologics Bone Solutions Inc. Successfully Surpasses 1,000 Implanted Cases with OsteoCrete® Magnesium-Based Bone Void Filler byJosh SandbergFebruary 25, 2020
Biologics Bone Solutions Inc. partners with Onkos Surgical for private label licensing agreement utilizing the OsteoCrete® platform technology byJosh SandbergAugust 28, 2019
Biologics WishBone Medical Adds Resorbable Implants to Product Offerings byJosh SandbergAugust 15, 2019
Biologics Bone Solutions Inc. Successfully surpasses 500 implanted cases with OsteoCrete® Magnesium-Based Bone Void Filler byJosh SandbergFebruary 26, 2019
Biologics Bone Solutions Inc. has successfully completed 250 cases with OsteoCrete® Magnesium-Based Bone Void Filler byJosh SandbergOctober 2, 2018
Spine In a First for the Orthopedic Industry, Bone Solutions of Dallas (BSI) Has Received Formal Patent Approval for Its Groundbreaking Magnesium Based Resorbable Bio-Material byJosh SandbergSeptember 14, 2015
